These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11035876)

  • 1. Statin drugs and the risk of fracture.
    El-Sohemy A
    JAMA; 2000 Oct; 284(15):1921; author reply 1922. PubMed ID: 11035876
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin drugs and the risk of fracture.
    El-Sohemy A
    JAMA; 2000 Oct; 284(15):1921-2. PubMed ID: 11035877
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stimulation of bone formation by statins].
    Komatsu Y; Nakao K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():783-8. PubMed ID: 15035227
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
    Yoneda T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
    [No Abstract]   [Full Text] [Related]  

  • 5. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study.
    Alam S; Ueki K; Nakagawa K; Marukawa K; Hashiba Y; Yamamoto E; Sakulsak N; Iseki S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):22-9. PubMed ID: 18755616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do statins prevent both cardiovascular disease and fracture?
    Cummings SR; Bauer DC
    JAMA; 2000 Jun; 283(24):3255-7. PubMed ID: 10866875
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study.
    Ozeç I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):605-6. PubMed ID: 19426916
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management.
    Coons JC
    Ann Pharmacother; 2002 Feb; 36(2):326-30. PubMed ID: 11847956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.
    Chan KA; Andrade SE; Boles M; Buist DS; Chase GA; Donahue JG; Goodman MJ; Gurwitz JH; LaCroix AZ; Platt R
    Lancet; 2000 Jun; 355(9222):2185-8. PubMed ID: 10881890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
    Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y
    J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitors and the risk of vertebral fracture.
    Schoofs MW; Sturkenboom MC; van der Klift M; Hofman A; Pols HA; Stricker BH
    J Bone Miner Res; 2004 Sep; 19(9):1525-30. PubMed ID: 15312254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitors and the risk of fractures.
    Meier CR; Schlienger RG; Kraenzlin ME; Schlegel B; Jick H
    JAMA; 2000 Jun; 283(24):3205-10. PubMed ID: 10866867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of BMP-related drugs].
    Kawate H; Ohnaka K; Takayanagi R
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():463-6. PubMed ID: 16279683
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins and osteoporosis: can these lipid-lowering drugs also bolster bones?
    Cruz AC; Gruber BL
    Cleve Clin J Med; 2002 Apr; 69(4):277-8, 280-2, 287-8. PubMed ID: 11996199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitors of HMG-CoA reductase in prevention of osteoporosis and bone fractures. Similar mechanism of action of statins and bisphosphonates].
    Stajszczyk M; Mykała-Cieśla J
    Pol Arch Med Wewn; 2002 Jan; 107(1):85-91. PubMed ID: 12046350
    [No Abstract]   [Full Text] [Related]  

  • 18. [Osteoporosis and bone morphogenetic protein (BMP)].
    Higuchi C; Nakase T
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():439-43. PubMed ID: 16279679
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of mevalonate pathway in osteogenic cells].
    Ishimi Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():779-82. PubMed ID: 15035226
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple effects of HMG-CoA reductase inhibitors (statins) besides their lipid-lowering function.
    Haslinger-Löffler B
    Kidney Int; 2008 Sep; 74(5):553-5. PubMed ID: 18709024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.